Metropolitan Life Insurance Company (MetLife)’s Collegium Pharmaceutical COLL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,847	Closed	-$71.7K	–	479
2024 Q1	$71.7K	Sell	1,847 -359	-16%	-$12.6K	﹤0.01%	1225
2023 Q4	$67.9K	Hold	2,206	–	–	﹤0.01%	1285
2023 Q3	$49.3K	Buy	2,206 +294	+15%	+$6.71K	﹤0.01%	1413
2023 Q2	$41.1K	Buy	+1,912	New	+$43.4K	﹤0.01%	1542
2023 Q1	–	Sell	-2,229	Closed	-$51.7K	–	2343
2022 Q4	$51.7K	Hold	2,229	–	–	﹤0.01%	1450
2022 Q3	$35.7K	Hold	2,229	–	–	﹤0.01%	1690
2022 Q2	$39.5K	Hold	2,229	–	–	﹤0.01%	1647
2022 Q1	$45.4K	Sell	2,229 -9,431	-81%	-$178K	﹤0.01%	1652
2021 Q4	$218K	Hold	11,660	–	–	﹤0.01%	1975
2021 Q3	$230K	Buy	+11,660	New	+$252K	﹤0.01%	1961
2021 Q2	–	Sell	-10,825	Closed	-$257K	–	2744
2021 Q1	$257K	Hold	10,825	–	–	﹤0.01%	1852
2020 Q4	$217K	Hold	10,825	–	–	﹤0.01%	1889
2020 Q3	$225K	Hold	10,825	–	–	﹤0.01%	1702
2020 Q2	$189K	Sell	10,825 -299	-3%	-$5.85K	﹤0.01%	1835
2020 Q1	$182K	Hold	11,124	–	–	﹤0.01%	1647
2019 Q4	$229K	Hold	11,124	–	–	﹤0.01%	1818
2019 Q3	$128K	Hold	11,124	–	–	﹤0.01%	2165
2019 Q2	$146K	Hold	11,124	–	–	﹤0.01%	2104
2019 Q1	$168K	Hold	11,124	–	–	﹤0.01%	2023
2018 Q4	$191K	Hold	11,124	–	–	﹤0.01%	1852
2018 Q3	$164K	Buy	+11,124	New	+$197K	﹤0.01%	2145

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s COLL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 1,847 shares — an estimated $71.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in COLL in Q3 2018 and held it in 21 quarters. The position peaked at $257K in Q1 2021. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,847 Collegium Pharmaceutical shares in Q2 2024, an estimated $71.7K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Collegium Pharmaceutical in Q3 2018 and held it in 21 quarters.
Metropolitan Life Insurance Company (MetLife)'s Collegium Pharmaceutical position peaked at $257K in Q1 2021.
229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.